0
0
6/12/23 at 7:29pm
Organization
The Times of India
Author
Durgesh Nandan Jha
41 words
0
Comments
The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vacci
You are the first to view
https://timesofindia.indiatimes.com/india/phase-3-trials-find-1-shot-chikungunya-vaccine-safe-effective-lancet/articleshow/100947278.cms
Create an account
or login to join the discussion